Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products

Injection Site Reaction Clinical Trial

Official title:
Prospective, Single Site, Controlled Comparative Study to Identify and Assess Tissue Responses After Injection With Various Biostimulatory Products

Status Active, not recruiting

Clinical Trial Summary

The objective of this study is to identify and assess in vivo tissue responses after injection with various biostimulatory products at various timepoints. The study will also provide tissue specimens which will be used in a subsequent study. Safety endpoint: incidence of adverse events.

Clinical Trial Description

The objective of this study is to identify and assess tissue responses after injection with various biostimulatory products that are already used in the market and have CE approval. The study will assess in vivo tissue responses and provide tissue specimens which will be used in a subsequent study, under a separate protocol. Assessments under this protocol will include ultrasound of in vivo tissue. Safety endpoint: incidence of adverse events. ;

Study Design

Related Conditions & MeSH terms

Injection Site Reaction

Clinical Trial Details

NCT number	NCT06093815
Study type	Interventional
Source	Merz North America, Inc.
Contact
Status	Active, not recruiting
Phase	N/A
Start date	September 8, 2023
Completion date	April 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05007041` - Simultaneous RZV and aIIV4 Vaccination	Phase 4
Completed	`NCT05157230` - Evaluation of Deltoid Exercises on Injection Site Pain After (BNT162b2) COVID - 19 Vaccination	N/A
Completed	`NCT05028361` - Simultaneous mRNA COVID-19 and IIV4 Vaccination Study	Phase 4
Completed	`NCT03645369` - Effectiveness of Mechano-Analgesia and Cold Application on Ecchymosis, Pain and Satisfaction at Subcutaneous Heparin Injection	N/A
Completed	`NCT03841396` - A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.	Phase 4
Recruiting	`NCT04962152` - Naldebain and Video-assisted Thoracoscopic Surgery	Phase 4
Completed	`NCT03183908` - FLUAD® vs. Fluzone® High-Dose Study	Phase 4
Recruiting	`NCT05221333` - Sorrel 25R Injector - Sorrel Clinical Study Protocol	N/A
Completed	`NCT05157191` - Safety of Pediatric COVID-19 Vaccination